1. Home
  2. APGE vs HHH Comparison

APGE vs HHH Comparison

Compare APGE & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$134.14

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Howard Hughes Holdings Inc.

HHH

Howard Hughes Holdings Inc.

HOLD

Current Price

$64.21

Market Cap

3.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
HHH
Founded
2022
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.8B
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
APGE
HHH
Price
$134.14
$64.21
Analyst Decision
Strong Buy
Buy
Analyst Count
13
2
Target Price
$109.67
$90.00
AVG Volume (30 Days)
1.2M
323.6K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$1,474,892,000.00
Revenue This Year
N/A
$14.04
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$463.00
Revenue Growth
N/A
N/A
52 Week Low
$34.34
$61.01
52 Week High
$134.46
$91.07

Technical Indicators

Market Signals
Indicator
APGE
HHH
Relative Strength Index (RSI) 79.86 34.04
Support Level $80.52 $61.79
Resistance Level N/A $65.99
Average True Range (ATR) 0.27 1.61
MACD -1.62 -0.70
Stochastic Oscillator 70.00 1.79

Price Performance

Historical Comparison
APGE
HHH

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About HHH Howard Hughes Holdings Inc.

Howard Hughes Holdings Inc, through its subsidiary, operates a large-scale, mixed-use real estate platform focused on the development of master planned communities (MPCs), the investment in strategic real estate development opportunities, and the ownership and operation of income-producing properties. The group operates through three reportable business segments: Operating Assets, MPCs, and Strategic Developments. Maximum revenue is generated from the MPC segment, which consists of the development and sale of land in large-scale, long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. Revenues are mainly generated through the sale of residential and commercial land to homebuilders and developers.

Share on Social Networks: